Related content

Postmenopausal breast cancer, androgens, and aromatase inhibitors

By Campagnoli C.  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy

By              

Experimental and Therapeutic Medicine, Vol. 5, Iss. 3, 2013-01 ,pp. : 902-906

Spandidos Publications

Access to resources Recommend Favorite

Aromatase inhibitors reverse tamoxifen induced endometrial ultrasonographic changes in postmenopausal breast cancer patients

By Markovitch O.   Tepper R.   Fishman A.   Aviram R.   Cohen I.  

Breast Cancer Research and Treatment, Vol. 101, Iss. 2, 2007-01 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite

Long-term “protective” effect of aromatase inhibitors on the endometrium of postmenopausal breast cancer patients

By Markovitch O.  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 321-326

Springer Publishing Company

Access to resources Recommend Favorite

Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer

By Dent Susan  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 295-310

Springer Publishing Company

Access to resources Recommend Favorite